Pages that link to "Q40604705"
Jump to navigation
Jump to search
The following pages link to Proteasome inhibitor MG132 upregulates death receptor 5 and cooperates with Apo2L/TRAIL to induce apoptosis in Bax-proficient and -deficient cells (Q40604705):
Displaying 50 items.
- CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells (Q24301679) (← links)
- Molecular targets of TRAIL-sensitizing agents in colorectal cancer (Q26822382) (← links)
- Trailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer Cells (Q28391040) (← links)
- Classical swine fever virus NS2 protein promotes interleukin-8 expression and inhibits MG132-induced apoptosis (Q33394120) (← links)
- Protein kinase Cbeta modulates ligand-induced cell surface death receptor accumulation: a mechanistic basis for enzastaurin-death ligand synergy. (Q33569854) (← links)
- Celastrol, a triterpene, enhances TRAIL-induced apoptosis through the down-regulation of cell survival proteins and up-regulation of death receptors (Q33799792) (← links)
- Modulation of TRAIL resistance in colon carcinoma cells: different contributions of DR4 and DR5. (Q33805582) (← links)
- DR5 knockout mice are compromised in radiation-induced apoptosis (Q33861644) (← links)
- 5-allyl-7-gen-difluoromethoxychrysin enhances TRAIL-induced apoptosis in human lung carcinoma A549 cells (Q33975484) (← links)
- F-box protein 10, an NF-κB-dependent anti-apoptotic protein, regulates TRAIL-induced apoptosis through modulating c-Fos/c-FLIP pathway (Q34160097) (← links)
- Legionella pneumophila induces cathepsin B-dependent necrotic cell death with releasing high mobility group box1 in macrophages (Q34412046) (← links)
- Targeted therapy of the XIAP/proteasome pathway overcomes TRAIL-resistance in carcinoma by switching apoptosis signaling to a Bax/Bak-independent 'type I' mode (Q34736820) (← links)
- Proteasome inhibitors-mediated TRAIL resensitization and Bik accumulation (Q35070129) (← links)
- Casticin-induced apoptosis involves death receptor 5 upregulation in hepatocellular carcinoma cells (Q35545730) (← links)
- Proteasome inhibition can impair caspase-8 activation upon submaximal stimulation of apoptotic tumor necrosis factor-related apoptosis inducing ligand (TRAIL) signaling. (Q35922585) (← links)
- TRAIL and its receptors as targets for cancer therapy (Q35927476) (← links)
- TNF-related apoptosis-inducing ligand as a therapeutic agent in autoimmunity and cancer (Q36365504) (← links)
- Analysis of changes in the proteome of HL-60 promyeloid leukemia cells induced by the proteasome inhibitor PSI. (Q36807352) (← links)
- Treating metastatic solid tumors with bortezomib and a tumor necrosis factor-related apoptosis-inducing ligand receptor agonist antibody (Q37367298) (← links)
- TRAIL receptor signaling and therapeutics. (Q37785559) (← links)
- Resistance to TRAIL and how to surmount it. (Q37992546) (← links)
- MG132, a proteasome inhibitor, induces apoptosis in tumor cells (Q38035077) (← links)
- Inhibition of hepatitis E virus replication by proteasome inhibitor is nonspecific (Q38932122) (← links)
- Proteasome inhibitor inhibits proliferation and induces apoptosis in renal interstitial fibroblasts (Q39036561) (← links)
- Doxorubicin sensitizes human tumor cells to NK cell- and T-cell-mediated killing by augmented TRAIL receptor signaling (Q39179377) (← links)
- TRAIL promotes membrane blebbing, detachment and migration of cells displaying a dysfunctional intrinsic pathway of apoptosis (Q39239250) (← links)
- Novel insights into the synergistic interaction of Bortezomib and TRAIL: tBid provides the link (Q39500830) (← links)
- 5, 7-Dimethoxyflavone sensitizes TRAIL-induced apoptosis through DR5 upregulation in hepatocellular carcinoma cells (Q39527243) (← links)
- Proteasome inhibitors sensitize glioma cells and glioma stem cells to TRAIL-induced apoptosis by PKCε-dependent downregulation of AKT and XIAP expressions (Q39569903) (← links)
- Programmed cell death 4 (PDCD4) mediates the sensitivity of gastric cancer cells to TRAIL-induced apoptosis by down-regulation of FLIP expression (Q39686052) (← links)
- The anti-apoptotic protein BCL2L1/Bcl-xL is neutralized by pro-apoptotic PMAIP1/Noxa in neuroblastoma, thereby determining bortezomib sensitivity independent of prosurvival MCL1 expression. (Q39755661) (← links)
- Reactive oxygen species up-regulate p53 and Puma; a possible mechanism for apoptosis during combined treatment with TRAIL and wogonin (Q39852248) (← links)
- Inhibition of Yin Yang 1-dependent repressor activity of DR5 transcription and expression by the novel proteasome inhibitor NPI-0052 contributes to its TRAIL-enhanced apoptosis in cancer cells (Q39990380) (← links)
- P53-mediated upregulation of DcR1 impairs oxaliplatin/TRAIL-induced synergistic anti-tumour potential in colon cancer cells (Q40001770) (← links)
- Upregulation of DR5 by proteasome inhibitors potently sensitizes glioma cells to TRAIL-induced apoptosis. (Q40002391) (← links)
- Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis (Q40052770) (← links)
- DcR2 (TRAIL-R4) siRNA and adenovirus delivery of TRAIL (Ad5hTRAIL) break down in vitro tumorigenic potential of prostate carcinoma cells (Q40081513) (← links)
- LY303511 amplifies TRAIL-induced apoptosis in tumor cells by enhancing DR5 oligomerization, DISC assembly, and mitochondrial permeabilization (Q40116602) (← links)
- Resistance of melanoma cells to TRAIL does not result from upregulation of antiapoptotic proteins by NF-kappaB but is related to downregulation of initiator caspases and DR4. (Q40198109) (← links)
- Proteasome inhibition induces hepatic stellate cell apoptosis (Q40324324) (← links)
- Potential mechanism of resistance to TRAIL-induced apoptosis in Burkitt's lymphoma (Q40341132) (← links)
- The HTLV-I Tax oncoprotein targets the retinoblastoma protein for proteasomal degradation (Q40484581) (← links)
- Natural Killer Cell Response to Chemotherapy-Stressed Cancer Cells: Role in Tumor Immunosurveillance. (Q42042886) (← links)
- The proteasome is required for rapid initiation of death receptor-induced apoptosis (Q42046723) (← links)
- Mcl-1 is downregulated in cisplatin-induced apoptosis, and proteasome inhibitors restore Mcl-1 and promote survival in renal tubular epithelial cells (Q42508560) (← links)
- Proteasome inhibitor MG132 sensitizes HPV-positive human cervical cancer cells to rhTRAIL-induced apoptosis. (Q46803231) (← links)
- Small-molecule CB002 restores p53 pathway signaling and represses colorectal cancer cell growth. (Q48022086) (← links)
- Proteasome Inhibitor Carbobenzoxy-L-Leucyl-L-Leucyl-L-Leucinal (MG132) Enhances Therapeutic Effect of Paclitaxel on Breast Cancer by Inhibiting Nuclear Factor (NF)-κB Signaling (Q49575918) (← links)
- NF-kappaB-independent sensitization of glioblastoma cells for TRAIL-induced apoptosis by proteasome inhibition. (Q55469625) (← links)
- A new TRAIL to therapy of hepatocellular carcinoma: blocking the proteasome (Q81100364) (← links)